Verve Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $99k | 8.8k | 11.23 |
| 2025-03-31 | $18k | 3.9k | 4.57 |
| 2024-12-31 | $76k | 13k | 5.64 |
| 2024-09-30 | $127k | 26k | 4.84 |
| 2024-06-30 | $121k | 25k | 4.88 |
| 2024-03-31 | $17k | 1.2k | 13.28 |
| 2023-09-30 | $28k | 2.1k | 13.26 |
| 2023-06-30 | $67k | 3.5k | 18.75 |
| 2023-03-31 | $91k | 6.3k | 14.37 |
| 2022-12-31 | $116k | 6.0k | 19.44 |
| 2022-09-30 | $246k | 6.1k | 40.00 |
| 2022-06-30 | $32k | 2.3k | 13.89 |
| 2022-03-31 | $88k | 3.8k | 23.08 |
| 2021-12-31 | $217k | 5.8k | 37.14 |
| 2021-09-30 | $52k | 1.1k | 47.56 |